Clinical Characteristics and Survival in Adenoid Cystic Carcinoma of Salivary and Nonsalivary Sites
On multivariate analysis controlling for age, sex, treatment, T and N classification, only breast primaries had significantly different survival from major salivary primaries (HR 0.59, 95% CI 0.49-0.72).
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- 20‑Year Risks of Breast‑Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- Breast Cancer: The good, the bad, and an important call to effective risk reduction strategies
- Clinical Trials in Cancer - Transforming Clinical Research in the United States - NCBI Bookshelf
- Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing
- The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21st century: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors - PMC